Lung Function Testing On and Off Dopaminergic Medication in Parkinson's Disease Patients With and Without Dysphagia

Tareq Sawan, Mary Louise Harris, Christopher Kobylecki, Laura Baijens, Michel van Hooren, Emilia Michou

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Swallowing function in individuals with Parkinson's disease (PD) can be negatively affected by dopaminergic medication with associated inhibition of brainstem reflexes. Three different "swallowing-safety" profiles of PD patients were previously observed, classified according to swallowing safety on and off levodopa.

Methods: Here, we investigated the effects of l-dopa on pulmonary function tests (PFTs) on 26 individuals with PD from the three different swallowing-safety profiles. PFTs results were compared to predicted values and direct comparisons between the groups with or without dysphagia were performed with nonparametric statistical tests (i.e., Kruskal-Wallis).

Results: A short (12-hour) withdrawal from l-dopa did not result in any significant changes in PFTs, and no differences on PFTs results were observed between the different dysphagic groups the on and off l-dopa state. No correlation was observed between the PFTs results with swallowing safety profiles of PD patients.

Conclusions: Although deglutition seems to be at least partially affected by dopaminergic repletion, dopaminergic mechanisms do not seem to be responsible for PD patients' performance in PFTs.

Original languageEnglish
Pages (from-to)146-150
Number of pages5
JournalMovement Disorders Clinical Practice
Volume3
Issue number2
DOIs
Publication statusPublished - 4 Nov 2015

Fingerprint

Dive into the research topics of 'Lung Function Testing On and Off Dopaminergic Medication in Parkinson's Disease Patients With and Without Dysphagia'. Together they form a unique fingerprint.

Cite this